Generic Depakote
Links shared publicly online about this topic
Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote... -- WALTHAM, Mass., Aug. 25 /PRNewswire/ --
prnewswire.com — “Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market. Dainippon Sumitomo Pharma/Sepracor's Lurasidone Will Become a Market Leader in 2019, According to Findings from Decision Resources.” View full resource at prnewswire.com
Most Recently Shared on August 25, 2010 at 1:56 pm By:
Peter H Brown Doctor and Psychologist
Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and ... http://bit.ly/9JdAQI #bipolar
Aurobindo Pharma gets USFDA approval for CNS drug - Economic Times
articles.economictimes.indiatimes.com — “NEW DELHI: Aurobindo Pharma today said it has received US health regulator's approval to manufacture and sell generic Divalproex Sodium Delayed-Release tablets, used in the treatment of central” View full resource at articles.economictimes.indiatimes.com
Most Recently Shared on April 27, 2011 at 12:28 pm By:
Terri Schmitt Nurse and Advanced Practice Nurse
Generic Depakote! It is about TIME! My patients w/o insurance find this med expensive - http://bit.ly/hqg03k #nurse
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Terri Schmitt
Spreading the important word about how Nursing can change Health Care. Faculty, NP, and student myself.
Advertisement
